Dr. Lal Path Labs Stock Screener | Share Price & Fundamental Analysis
LALPATHLAB
Healthcare Service Provider
Share Price NSE
₹1363.20
▲
10.90 (0.81%)
Share Price BSE
₹1365.80
▲
13.90 (1.03%)
Track Dr. Lal Path Labs share price live with TickJournal's free stock screener.
Analyze Dr. Lal Path Labs share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Dr. Lal Path Labs Market Cap
₹22,263.00 Cr.
LALPATHLAB P/E Ratio (TTM)
41.78
Dr. Lal Path Labs P/B Ratio
9.33
EPS (TTM)
₹58.48
Dividend Yield
0.90%
Debt to Equity
0.10
LALPATHLAB 52 Week High
₹3450.90
Dr. Lal Path Labs 52 Week Low
₹1307.60
Operating Margin
23.00%
Profit Margin
13.30%
LALPATHLAB Revenue (TTM)
₹684.00
EBITDA
₹174.00
Net Income
₹91.00
Total Assets
₹2,717.00
Total Equity
₹2,207.00
Dr. Lal Path Labs Share Price History - Stock Screener Chart
Screen LALPATHLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Dr. Lal Path Labs Company Profile - Fundamental Screener
Screen Dr. Lal Path Labs company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for LALPATHLAB shares.
Dr Lal PathLabs is a leading diagnostic healthcare service provider in India. The company operates a nationwide network of medical laboratory centers, offering over 5000 diagnostic tests and related healthcare services. Its infrastructure includes a National Reference Laboratory in New Delhi, Regional Reference Labs in Kolkata, Bangalore, and Mumbai, 371...more
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
Chairperson/CEO
Arvind Lal
ISIN
INE600L01024
Website
https://www.lalpathlabs.com
Dr. Lal Path Labs Balance Sheet Screener
Screen LALPATHLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 2,717 | 2,456 | 2,386 | 2,353 | 1,661 | 1,374 | 1,091 | 916 | 764 | 625 |
| Current Assets | 1,364 | 1,127 | 973 | 875 | 1,145 | 893 | 814 | 623 | 511 | 424 |
| Fixed Assets | 1,168 | 1,228 | 1,305 | 1,375 | 447 | 413 | 209 | 208 | 190 | 166 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 108 | 105 | 216 | 310 | 111 | 93 | 1 | 8 | 28 | 24 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,207 | 1,885 | 1,700 | 1,544 | 1,276 | 1,054 | 951 | 792 | 662 | 510 |
| Share Capital | 84 | 84 | 83 | 83 | 83 | 83 | 83 | 83 | 83 | 83 |
| Reserves & Surplus | 2,089 | 1,766 | 1,583 | 1,425 | 1,162 | 974 | 890 | 734 | 577 | 424 |
Dr. Lal Path Labs Income Statement Screener - Profit & Revenue Analysis
Screen Dr. Lal Path Labs income statement and profit fundamentals.
Analyze LALPATHLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Dr. Lal Path Labs share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 684 | 755 | 698 | 628 | 622 | 682 | 623 | 564 | 557 | 619 | 555 | 505 | 500 | 543 | 511 |
| Expenses | 511 | 507 | 478 | 434 | 443 | 458 | 432 | 401 | 398 | 424 | 395 | 375 | 376 | 390 | 385 |
| EBITDA | 174 | 249 | 220 | 195 | 179 | 224 | 191 | 163 | 159 | 196 | 161 | 130 | 124 | 153 | 126 |
| Operating Profit % | 23.00% | 31.00% | 29.00% | 28.00% | 26.00% | 31.00% | 28.00% | 27.00% | 26.00% | 30.00% | 27.00% | 24.00% | 23.00% | 27.00% | 23.00% |
| Depreciation | 42 | 41 | 35 | 36 | 36 | 35 | 35 | 37 | 36 | 36 | 35 | 38 | 38 | 39 | 36 |
| Interest | 7 | 5 | 5 | 5 | 5 | 6 | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 11 | 9 |
| Profit Before Tax | 124 | 204 | 181 | 153 | 138 | 183 | 150 | 120 | 116 | 152 | 118 | 83 | 77 | 103 | 81 |
| Tax | 33 | 51 | 47 | -2 | 40 | 52 | 42 | 34 | 34 | 42 | 34 | 26 | 23 | 30 | 23 |
| Net Profit | 91 | 152 | 134 | 156 | 98 | 131 | 108 | 86 | 82 | 111 | 84 | 57 | 54 | 72 | 58 |
| EPS | 5.42 | 18.05 | 15.88 | 18.57 | 11.60 | 15.52 | 12.79 | 10.13 | 9.77 | 13.16 | 9.95 | 6.84 | 6.37 | 8.64 | 6.97 |
Dr. Lal Path Labs Cash Flow Screener - Liquidity Fundamentals
Screen LALPATHLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 569 | 535 | 456 | 447 | 398 | 284 | 219 | 197 | 171 | 159 |
| Investing Activities | -303 | -24 | -287 | -449 | -212 | -26 | -100 | -172 | -137 | -164 |
| Financing Activities | -334 | -414 | -283 | 136 | -139 | -190 | -55 | 13 | -32 | 0 |
| Net Cash Flow | -68 | 97 | -115 | 134 | 48 | 67 | 64 | 37 | 2 | -5 |
Dr. Lal Path Labs Shareholding Pattern Screener
See Dr. Lal Path Labs shareholding pattern with promoter, FII, and DII holdings.
Check Dr. Lal Path Labs promoter holding and ownership changes for LALPATHLAB on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 53.91% | 53.79% | 53.21% | 53.21% | 54.60% | 54.60% | 53.92% | 53.91% |
| FII Holding | 23.91% | 21.68% | 21.86% | 20.29% | 26.15% | 25.42% | 26.82% | 26.82% |
| DII Holding | 16.08% | 17.91% | 18.49% | 19.21% | 9.69% | 12.71% | 12.89% | 13.17% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 4.11% | 5.23% | 5.19% | 5.82% | 6.47% | 4.91% | 4.10% | 4.01% |
| Other Holding | 2.00% | 1.38% | 1.25% | 1.47% | 3.09% | 2.35% | 2.27% | 2.10% |
| Shareholder Count | 115,699 | 118,656 | 112,703 | 114,385 | 146,741 | 131,189 | 116,606 | 116,236 |
Dr. Lal Path Labs Share Dividend Screener - Share Yield Analysis
Check Dr. Lal Path Labs dividend history with payout and yield data.
View Dr. Lal Path Labs dividend details including ex-dates and amounts for LALPATHLAB stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹24.00 | 1.83% |
| 2024-March | ₹24.00 | 1.94% |
| 2023-March | ₹12.00 | 1.06% |
| 2022-March | ₹12.00 | 1.31% |
| 2021-March | ₹20.00 | 1.53% |
| 2020-March | ₹12.00 | 0.89% |
| 2019-March | ₹6.00 | 0.86% |
| 2018-March | ₹4.50 | 0.86% |
| 2017-March | ₹3.00 | 0.68% |
Dr. Lal Path Labs Stock Index Membership
See which indices include Dr. Lal Path Labs stock.
Check LALPATHLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX BSE500
BSE INDEX MSL400
BSE INDEX SML250
BSE INDEX SMLCAP
BSE INDEX SMLSEL
NIFTY 500
NIFTY MIDSMALLCAP400 MOMENTUM QUALITY 100
NIFTY MIDSML 400
NIFTY MIDSML HLTH
NIFTY SMALLCAP250 MOMENTUM QUALITY 100
NIFTY SMALLCAP250 QUALITY 50
NIFTY SMLCAP 100
NIFTY SMLCAP 250
NIFTY SMLCAP 50
NIFTY TOTAL MKT
NIFTY500 EQUAL WEIGHT
NIFTY500 LARGEMIDSMALL EQUAL CAP WEIGHTED
NIFTY500 MULTICAP
Dr. Lal Path Labs Market Events Screener - Corporate Actions
Get Dr. Lal Path Labs corporate actions including splits, bonuses, and buybacks.
Check Dr. Lal Path Labs stock events that may affect LALPATHLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-02-05 | 2026-02-05 | Dividend | ₹ 3.50 /share | 0.85% |
| 2026-01-30 | 2026-01-30 | Quarterly Result Announcement | NA | -0.75% |
| 2025-12-19 | 2025-12-19 | Bonus | 1:1 | -3.25% |
| 2025-11-07 | 2025-11-07 | Dividend | ₹ 7.00 /share | 0.60% |
| 2025-10-31 | 2025-10-31 | Quarterly Result Announcement | NA | 0.59% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 6.00 /share | 3.08% |
| 2025-07-31 | 2025-07-31 | Quarterly Result Announcement | NA | 2.72% |
| 2025-06-28 | 2025-06-28 | Annual General Meeting | NA | -0.61% |
| 2025-06-06 | 2025-06-06 | Dividend | ₹ 6.00 /share | 2.46% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | 2.73% |
| 2025-02-06 | 2025-02-06 | Extraordinary General Meeting | NA | 0.00% |
| 2025-02-05 | 2025-02-05 | Dividend | ₹ 6.00 /share | 2.56% |
| 2025-01-30 | 2025-01-30 | Quarterly Result Announcement | NA | -2.95% |
| 2024-11-05 | 2024-11-05 | Dividend | ₹ 6.00 /share | -7.31% |
| 2024-10-23 | 2024-10-23 | Quarterly Result Announcement | NA | -2.43% |
Dr. Lal Path Labs Competitors Screener - Peer Comparison
Screen LALPATHLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 22,263 | 41.78 | 2,555 | 11.28% | 492 | 43.78 |
| Vijaya Diagnostic Centre | 9,230 | 57.65 | 700 | 23.06% | 144 | 40.76 |
| Metropolis Healthcare | 8,744 | 51.77 | 1,346 | 10.64% | 146 | 32.04 |
| Thyrocare Technologies | 5,826 | 42.92 | 702 | 20.80% | 91 | 45.58 |
| Nephrocare Health Services | 5,304 | 74.15 | 770 | 33.97% | 67 | 47.46 |
| Krsnaa Diagnostics | 1,786 | 22.12 | 743 | 16.70% | 78 | 36.51 |
| Suraksha Diagnostic | 1,276 | 39.31 | 256 | 15.11% | 31 | 41.69 |
| One Global Service Provider | 1,058 | 16.99 | 148 | 134.60% | 19 | 44.50 |
| 3B BlackBio DX | 1,054 | 18.13 | 112 | 28.72% | 48 | 46.16 |
| Sastasundar Ventures | 864 | 29.42 | 1,171 | -18.47% | -134 | 44.69 |
Dr. Lal Path Labs Company Announcements - News Screener
Screen LALPATHLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-30 | Board Meeting Intimation for Notice Of Board Meeting | - |
| 2026-03-25 | Announcement under Regulation 30 (LODR)-Credit Rating | - |
| 2026-03-19 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-12 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-10 | Update On Voluntary Liquidation Of Suburban Diagnostics (India) Private Limited (A Wholly Owned Subsidiary Of The Company)-Receipt Of NCLT Order | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-31 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-01-30 | Fixes Record Date For 3Rd Interim Dividend FY 2025-26 | - |
| 2026-01-30 | Corporate Action-Board approves Dividend | - |
| 2026-01-30 | Board Meeting Outcome for Outcome Of Board Meeting Dated January 30 2026 | - |
| 2026-01-30 | Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-30 | Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-23 | Update on board meeting | - |
| 2026-01-23 | Corporate Action-Board to consider Dividend | - |